CTRI/2024/03/063784
Not yet recruiting
未知
A randomised controlled clinical trial to evaluate the efficacy of shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in anovulatory cycles in pcos. - NI
Chaitalee Rajendra Jain0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Sponsor
- Chaitalee Rajendra Jain
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis with case of pcos with ovulatory dysfunctions, Anovulatory cycle, irregular menses
Exclusion Criteria
- •1\) patient having systemic disease like DM, HTN
- •2\) Menorrhagia in PCOS
- •3\) Patient having Anorectal disease
- •4\) patient having Headache, Migraine,Sinusitis, congestion or any other upper respiratory tract disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to compare effect of kushmand choornavati with Tagar ghanvati as anxiolytic and sedative as pre-medication in spinal anaesthesiaHealth Condition 1: F409- Phobic anxiety disorder, unspecifiedCTRI/2020/01/022835PDEAS College of Ayurved and research centre
Terminated
Phase 3
Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.SmokingMental illnessDrug and alcohol dependenceMental Health - AddictionMental Health - Other mental health disordersACTRN12616001355460The University of Auckland15
Recruiting
Phase 2
A trial examining the use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for children undergoing microlaryngoscopy and bronchoscopyRespiratory diseaseAnaesthesiology - AnaestheticsRespiratory - Other respiratory disorders / diseasesACTRN12617000799358Auckland District Health Board250
Completed
Not Applicable
A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancerISRCTN83688026Royal Marsden Hospital (UK), secondary sponsor Schering (Germany)1,000
Completed
Not Applicable
High dose fluconazole with or without flucytosine in the treatment of human immunodeficiency virus (HIV)-associated cryptococcal meningitiscryptococcal meningitisCryptococcal meningitis/ HIVInfections and InfestationsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesISRCTN02725351St George's University of London (UK)80